Essa Pharma Inc Reports Results For The Quarter Ended In December: Earnings Summary

ESSA Pharma

07/02/2023 13:00

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted
loss
of 15 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 23 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ESSA Pharma Inc's reported EPS for the quarter was a loss
of 15
cents​.
    * The mean earnings estimate of analysts had risen by
about 28.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ESSA Pharma Inc shares had risen by 15.1% this quarter.
    * The company reported a quarterly loss of $6.74 million.
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $21.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
7 at 01:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.23          -0.15          Beat
 Sep. 30 2022      -0.27          -0.14          Beat
 Jun. 30 2022      -0.27          -0.20          Beat
 Mar. 31 2022      -0.25          -0.25          Met